Atlas Trials

WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC

Clinical trial NCT03481101 · UNKNOWN

Trial details

NCT number
NCT03481101
Sponsor
Rigshospitalet, Denmark
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Non Small Cell Lung CancerCirculating Tumor CellCirculating Tumor DNA
Start date
2018-02-28
Primary completion
2021-02-26
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.